Financière de Tubize SA, through its participation in UCB, operates as a global biopharmaceutical company. Discover and develop medicines and solutions in the therapeutic areas of neurological and immunological diseases. The company’s principal products include Cimzia for the treatment of ankylosing spondylitis, axial spondyloarthritis, Crohn’s disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis and rheumatoid arthritis; Briviact, Vimpat, and Keppra for the treatment of partial-onset seizures; Nayzilam, a nasal spray; and Neupro for the treatment of Parkinson’s disease and restless legs syndrome. It also offers Zyrtec and Xyzal for allergy treatment; Nootropil for the treatment of psycho-organic syndromes or cognitive impairment and cortical myoclonus; and Xyrem for use in the treatment of narcolepsy with cataplexy in adult patients. The company’s products in development include padsevonil for drug-resistant epilepsy; UCB0107 for the treatment of progressive supranuclear palsy; UCB0599 for Parkinson’s disease; UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. Financière de Tubize SA is headquartered in Brussels, Belgium. UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. Financière de Tubize SA is headquartered in Brussels, Belgium. UCB7858 for autoinflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium. and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is headquartered in Brussels, Belgium.
How to buy shares of Financière de Tubize (FTD.F), Step by step in English
Would you like to obtain shares of Financière de Tubize (FTD.F) in Frankfurt from Spain and through a regulated and recognized broker? Are you interested in being able to invest your bank savings and earn interest on the stock market? Here I am going to show you how you can register with degiro , a regulated German investment bank with low commissions, and how you can get your first share in Financière de Tubize SA (FTD.F) (FTD.F) quickly and easily. .
The method to follow is simple :
- First of all, we are going to register on DeGiro, a broker platform where we are going to be able to buy shares of the company Financière de Tubize SA (FTD.F), (FTD.F).
- In this step we will make a transfer of euros and make the 1st investment.
- When we finally have the funds, we will proceed to look for the Financière de Tubize company with its ticker, in this case it is FTD.F.
- Then we will only go on to indicate the number of shares we want, value and the type of order.
The summary may have been a bit essential for you, so I will summarize the procedure with images:
How to open your account in DEGIRO.
First of all, we will register an account with DeGiro through the following link :
It will ask us for an email, a username and a password to enter, and then we must continue using the link that they have sent us by email address.
Soon DEGIRO will ask us for some essential data in order to validate that it is us . We will need to have at hand our passport number, identity document or driving document, mobile or cell phone and the number of the bank account that we will apply to make our 1st deposit in IBAN format. If you don’t understand what this format looks like, you can review this simple guide article we’ve put together .
Once our account is accepted, we can pay money from the Enter/Withdraw tab. We will be able to carry out a transaction that will take more or less two to three days, or make the deposit quickly using Sofort, a 100% secure and 100% reliable payment gateway.
How to buy shares of Financière de Tubize (FTD.F) via degiro
As soon as we have the money we have the possibility of obtaining our first share. You can select the «Place Order» button in the top right or select the DeGiro search engine and type in the ticker. In the next screenshot you will notice that I have used the Amazon Ticker but you should write (FTD.F), the Financière de Tubize ticker. As we are talking about an action, we will discover that the related businesses and companies are listed and there we will see Financière de Tubize. The most important thing is that the ticker, the name of the action and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case Financière de Tubize SA (FTD.F) is listed in Frankfurt. This step is important so make no mistake.
At the moment of placing the order we have to pay attention to what I will explain to you . We can proceed to place a limit or market order. Think that you want to get a share of Financière de Tubize, but its price today is much higher. With this limit order we will enter the value at which we wish to make the purchase and until there are no shares for sale at this price, the purchase of the share will not be executed. With a market order, DEGIRO will buy the number of shares that we have indicated at the true selling price, which will be closely related to the actual listing price.
In all cases it is essential that you look at the type of organization: fixed or daily . For example, in Spain, the stock market listing is in the morning and until 1 in the afternoon, and in the US it corresponds to the afternoon schedule in Spain. If an order is fixed, it will be there until it is executed, but if you opt for the “of the day” option, at the end of the trading day, if it is not carried out, it will be removed from your Activity panel – Orders in Pending status.
I wish this simple article helped you to buy shares in Financière de Tubize. THANK YOU!
| Company information |
|
key executives
| Name | Title | Salary | exercised | Year of birth |
|---|---|---|---|---|
| Mr. Gaëso Hannecart | president and president | 7k | N/A | N/A |
| Ms Anne Sophie Pijcke | Gen. Mang. | 92.33k | N/A | N/A |
| Marc Van Steenvoort | Gen. Mang. | N/A | N/A | N/A |
Recent events of :
We have no recent events for this company.